Opioid-induced constipation (OIC) is a common symptom in patients. Naloxegol has been proved to be helpful in relieving the pain caused by cancer. The purpose of this study is to compare the effect of naloxegol versus the patient's usual care in treating opioid-induced constipation, as well as the effect on the patient's quality of life and how much pain is experienced.
|Study Type :
||Interventional (Clinical Trial)
|Estimated Enrollment :
||None (Open Label)
||A Phase II, Randomized, Single Center, Pilot Feasibility Study to Evaluate Naloxegol for Opioid-Induced Constipation in Cancer Patients
|Study Start Date :
|Estimated Primary Completion Date :
|Estimated Study Completion Date :
For enrollment please visit www.clinicaltrials.gov.